Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

3.3
CiteScore 2024
3.3
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE

    Alberto L. García-Basteiro, Quique Bassat, Pedro L. Alonso
    e2012015
    2012-03-10
    https://doi.org/10.4084/mjhid.2012.015
    2462
    PDF: 890
    HTML: 15064
  • INFLUENZA AND PNEUMOCOCCAL VACCINATION IN HEMATOLOGICAL MALIGNANCIES: A SYSTEMATIC REVIEW OF EFFICACY, EFFECTIVENESS AND SAFETY

    Giuseppe La Torre
    e2016044
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.044
    4559
    PDF: 1405
    HTML: 3128
  • BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES

    Giuseppe Leone, Eligio Pizzigallo
    e2015057
    2015-10-12
    https://doi.org/10.4084/mjhid.2015.057
    4627
    PDF: 1904
    HTML: 8269
  • EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies

    Mehran Karimi, Tahereh Zarei, Sezaneh Haghpanah , Azita Azarkeiva, Maryam Naderi , Sara Matin , Asghar Bazrafshan , Zohreh Zahedi , Afshan Shirkavand , Parisa pishdad, Vincenzo De Sanctis
    e2022026
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.026
    1432
    PDF: 682
    HTML: 212
  • Immune thrombocytopenic purpura cases following COVID-19 vaccination.

    Annalisa Condorelli, Uros Markovic, Roberta Sciortino, Mary Ann Di Giorgio, Daniela Nicolosi, Gaetano Giuffrida
    e2021047
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.047
    1057
    PDF: 382
    HTML: 295
  • PREVALENCE AND AETIOLOGY OF BACTEREMIA IN FEBRILE CHILDREN WITH SICKLE CELL DISEASE AT A NIGERIA TERTIARY HOSPITAL

    Biobele Jotham Brown, Hannah O Dada-Adegbola, Catherine Trippe, Olufunmilayo Olopade
    e2017039
    2017-06-20
    https://doi.org/10.4084/mjhid.2017.039
    2839
    PDF: 1158
    HTML: 989
  • PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID

    Francesco Rodeghiero
    e2021032
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.032
    2266
    PDF: 869
    HTML: 462
  • Antibody response to breakthrough SARS-CoV-2 infection in “booster” vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments

    NICOLA SGHERZA, Anna Mestice, Angela Maria Vittoria Larocca, Pellegrino Musto
    e2024022
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.022
    670
    PDF: 1102
    HTML: 77
  • Sickle Cell Disease: Management options and challenges in developing countries

    Daniel Ansong, Alex Osei-Akoto, Delaena Ocloo, Kwaku Ohene-Frempong Ohene-Frempong
    e2013062
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.062
    2322
    PDF: 1210
    HTML: 981
  • SEROLOGICAL CHANGES AGAINST HEPATITIS B SURFACE ANTIGEN IN CHILDREN AND ADOLESCENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIA

    Seung Beom Han, Hye Jo Shin, Eui Soo Lee, Jae Wook Lee, Nack-Gyun Chung, Bin Cho, Jin Han Kang
    e2019052
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.052
    1086
    PDF: 759
    HTML: 180
  • Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)

    Salam Alkindi, Dr. , Dr.
    e2021059
    2021-09-01
    https://doi.org/10.4084/MJHID.2021.059
    1981
    PDF: 450
    HTML: 115
  • H1N1 influenza among hematological patients: monocentric influenza cases from 2011 to 2016.

    Elisabetta Metafuni, Rosaria Santangelo, Patrizia Chiusolo, Luca Laurenti, Federica Sorà, Sabrina Giammarco, Simona Sica
    e2017024
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.024
    1817
    PDF: 654
    HTML: 720
  • Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP. immune thrombocytopenia following mRNA vaccine

    SIMONA BIANCHI, ALESSIA ANGI, MAURO PASSUCCI, GIOVANNA PALUMBO, ERMINIA BALDACCI, ANNA MARIA TESTI
    e2022011
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.011
    2037
    PDF: 509
    HTML: 1123
  • CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Rafael de la Camara
    e2016031
    2016-06-20
    https://doi.org/10.4084/mjhid.2016.031
    4678
    PDF: 1698
    HTML: 2685
    Untitled: 187
  • IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination

    Giuseppe Auteri, Simona Paglia, Camilla Mazzoni, Mattia Biondo, Marta Venturi, Andre Davide Romagnoli, Daniela Bartoletti, Michele Cavo, Nicola Vianelli, Francesca Palandri
    e2023029
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.029
    1230
    PDF: 743
    HTML: 291
  • Neutropenıa Secondary to Sars-Cov2 Vaccınatıon in Post-Hematopoıetıc Stem Cell Transplant (Hsct) Patıents

    LUIS MIGUEL JUAREZ-SALCEDO, Samantha Feijóo, Cristina García, Alejandro Alonso, Beatriz Aguado, Javier Ortiz, Angela Figuera, Rafael de la Cámara
    e2023014
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.014
    878
    PDF: 830
    HTML: 329
  • PREVALENCE OF SERIOUS BACTERIAL INFECTIONS IN CHILDREN WITH SICKLE CELL DISEASE AT KING ABDULAZIZ HOSPITAL, AL AHSA Bacterial infections in children with sickle cell diseas

    Manal Alsaif, Joan Robinson, Moshtag Abdulbaqi, Mustafa Aghbari, Khalid Al Noaim, Muneera Alabdulqader
    e2021002
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.002
    1389
    PDF: 528
    HTML: 193
  • THE DARK SIDE OF THE COVID-19 TREATMENTS ON MYCOBACTERIUM TUBERCULOSIS INFECTION

    Flavio De Maio, Delia Mercedes Bianco, Giovanni Delogu
    e2022021
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.021
    1177
    PDF: 716
    HTML: 214
  • Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients

    NICOLA SGHERZA, Stefania Zucano, Angelantonio Vitucci, Antonio Palma, Francesco Tarantini, Daniela Campanale, Luigi Vimercati, Angela Maria Vittoria Larocca, Domenico Visceglie, Amalia Acquafredda, Angelo Ostuni, Daniela Di Gennaro, Carmen Vitucci, Silvio Tafuri, Pellegrino Musto
    e2022056
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.056
    924
    HTML: 257
    PDF: 473
  • PERCEPTION OF COMMUNITY HEALTH CARE WORKERS ABOUT PATIENTS WITH SICKLE CELL DISEASE IN PRIMARY HEALTH CARE AFTER AN EDUCATIONAL INTERVENTION

    Ludmila Mourão Xavier Gomes, Marcos Borato Viana, Igor Alcântara Pereira
    22015031
    2015-04-19
    https://doi.org/10.4084/mjhid.2015.031
    1991
    PDF: 930
    HTML: 1646
  • VACCINATION FOLLOWING LEUKEMIA TREATMENT: VIRAL VACCINE RESPONSES IN SURVIVORS OF ACUTE LYMPHOBLASTIC LEUKEMIA

    Elif Kilic Konte, Ayca Koca Yozgat, Aysun Kara Uzun, Bahar Cuhaci Cakir, Nese Yarali
    e2025049
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.049
    714
    PDF: 492
    HTML: 18
  • MALARIA IN PREGNANCY

    Ebako Ndip Takem, Umberto D'Alessandro
    e2013010
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.010
    4606
    PDF: 2036
    HTML: 7769
  • Humoral immune response after anti-SARS-CoV-2 vaccine “booster” dose in patients with monoclonal gammopathy of undetermined significance (MGUS)

    NICOLA SGHERZA, Paola Curci, Rita Rizzi, Angela Maria Vittoria Larocca, Luigi Vimercati, Silvio Tafuri, Maria Chironna, Pellegrino Musto
    e2023011
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.011
    864
    PDF: 893
    HTML: 418
  • PREVALENCE OF HPV HIGH-RISK GENOTYPES IN THREE COHORTS OF WOMEN IN OUAGADOUGOU (BURKINA FASO)

    Theodora M. Zohoncon, Jacques Simpore
    e2013059
    2013-09-01
    https://doi.org/10.4084/mjhid.2013.059
    1375
    PDF: 734
    HTML: 1984
  • NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2

    Mohsen Nakhaei, Zohreh-Al-Sadat Ghoreshi, Mohammad Rezaei Zadeh Rukerd, Hedyeh Askarpour, Nasir
    e2023059
    2023-10-16
    https://doi.org/10.4084/MJHID.2023.059
    837
    PDF: 424
    HTML: 101
  • A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 Ophthalmic vein thrombosis following Covid

    Irina Panovska-Stavridis
    e2021048
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.048
    1226
    PDF: 421
    HTML: 377
  • THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.

    Giovanni Delogu, Michela Sali, Giovanni Fadda
    e2013070
    2013-11-15
    https://doi.org/10.4084/mjhid.2013.070
    10220
    PDF: 6116
    HTML: 21737
  • COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

    Federico Mercolini, Simone Cesaro
    e2022009
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.009
    1942
    PDF: 895
    HTML: 275
  • Sinopharm Vaccine, SARS-CoV-2 breakthrough infections and Hemoglobinopathies

    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    e2022060
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.060
    623
    PDF: 427
    HTML: 186
  • Risk Factors of Hepatitis B Virus Infection in the Kurdistan Region of Iraq: A Cross-Sectional Study

    Nawfal R Hussein, Halder J Abozait, Ibrahim A Naqid, Nashwan MR Ibrahim, Fatima K Khalid, Dildar H Musa, Zana SM Saleem
    e2025018
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.018
    1129
    PDF: 841
    HTML: 118
  • THE IMPACT OF CHEMOTHERAPY AFTER PEDIATRIC MALIGNANCY ON HUMORAL IMMUNITY TO VACCINE-PREVENTABLE DISEASES

    Chiara Garonzi, Rita Balter, Gloria Tridello, Anna Pegoraro, Manuela Pegoraro, Monia Pacenti, Novella Scattolo, Simone Cesaro
    e2020014
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.014
    1498
    PDF: 931
    HTML: 262
  • Impact of Sars-CoV-2 prophylaxis with tixagevimab-cilgavimab in high-risk patients with B-cell malignancies: a single-center retrospective study.

    Giovanni Manfredi Assanto ,, Matteo Totaro , Poggiali Rebecca, Delli Paoli Adele, Annechini Giorgia, D’Elia Gianna Maria, Aji Francesco, Petrucci Luigi, Fazio Francesca, Del Giudice Ilaria, Martelli Maurizio, Micozzi Alessandra, Giuseppe Gentile
    e2023061
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.061
    711
    PDF: 378
    HTML: 101
  • EPIDEMIOLOGY OF MALARIA IN THE STATE OF QATAR, 2008-2015

    Elmoubasher Farag, Devendra Bansal, Mohamad Abdul Halim Chehab, Ayman Al-Dahshan, Mohamed Bala, Nandakumar Ganesan, Yosuf Abdulla Al Abdulla, Mohammed Al Thani, Ali H. Sultan, Hamad Al-Romaihi
    e2018050
    2018-09-01
    https://doi.org/10.4084/mjhid.2018.050
    1847
    PDF: 933
    HTML: 410
  • PREDICTORS OF MORTALITY IN MECHANICALLY VENTILATED CRITICAL PERTUSSIS IN A LOW INCOME COUNTRY: NEW RESURGENCE IN 2013.

    Aida Borgi
    e2014059
    2014-09-01
    https://doi.org/10.4084/mjhid.2014.059
    1177
    PDF: 734
    HTML: 1530
  • TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Marta Muzio, Eleonora Fonte, Federico Caligaris-Cappio
    e2012055
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.055
    2500
    PDF: 824
    HTML: 17436
    Fig1 Caligaris: 142
    Fig.2 Caliga: 175
  • SEQUENCE ANALYSIS OF HOT SPOT REGIONS OF SPIKE AND RNA‑DEPENDENT‑RNA POLYMERASE (RDRP) GENES OF SARS-COV-2 IN KERMAN, IRAN

    Nasir, Ramin, Amin, Jamal
    e2023042
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.042
    743
    PDF: 675
    HTML: 178
  • CHARACTERIZATION AND ANTIMICROBIAL SUSCEPTIBILITY PROFILE OF SEPTICAEMIA-CAUSING PATHOGENS ISOLATED FROM FEBRILE CHILDREN WITH SICKLE CELL DISEASE IN KANO, NIGERIA.

    Ibrahim Yusuf
    e2018016
    2018-02-15
    https://doi.org/10.4084/mjhid.2018.016
    2763
    PDF: 937
    HTML: 503
  • IMMUNOLOGY OF TUBERCULOSIS

    Federica Bozzano, Francesco Marras, Andrea De Maria
    e2014027
    2014-04-07
    https://doi.org/10.4084/mjhid.2014.027
    5086
    PDF: 1951
    HTML: 7244
    Untitled: 184
  • PLASMODIUM VIVAX INFECTIONS IN DUFFY-NEGATIVE INDIVIDUALS: A PARADIGM SHIFT IN INDIAN MALARIA EPIDEMIOLOGY Duffy negative malaria in India

    Roshan Shaikh, Kanjaksha Ghosh, Ajit Gorakshakar
    e2025044
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.044
    1063
    PDF: 748
    HTML: 60
  • RECENT INSIGHTS INTO THE POPULATION GENETICS AND DYNAMICS OF THE INHERITED DISORDERS OF HEMOGLOBIN

    David J Weatherall
    e2009022
    2009-12-20
    1011
    PDF: 438
    HTML: 516
  • DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE

    Hui Liu, Lorraine Gemmell, Rui Lin, Fengrong Zuo, Henry H. Balfour, Jr., Jennifer C. Woo, Gregory M. Hayes
    e2020016
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.016
    1690
    PDF: 996
    HTML: 316
  • IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES

    Silvia Maria Trisolini, Alessandro Laganà, Saveria Capria
    e2024060
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.060
    1908
    PDF: 1693
    HTML: 115
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 2- FOCUS ON THERAPY

    Michele Bibas, Shayna Sarosiek , Jorge Castillo
    e2025015
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.015
    2147
    PDF: 1892
    HTML: 175
  • Epidemiological surveillance of SARSCov2 in β-Thalassemia Patients in the last two years: reinfection rate, insights and future challenges

    Lorenza Torti, Francesco Sorrentino, Laura Maffei, Paolo De Fabritiis, Elisabetta Abruzzese
    e2023007
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.007
    798
    PDF: 888
    HTML: 377
  • FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator

    Claudio Ucciferri, Francesca Chiappini, Jacopo Vecchiet, Katia Falasca
    e2025057
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.057
    2004
    PDF: 823
    HTML: 287
  • Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation Pidotimod in SARS-CoV-2 vaccination

    Claudio Ucciferri, Antonio Auricchio, Jacopo Vecchiet, Katia Falasca
    e2022023
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.023
    1009
    PDF: 505
    HTML: 203
  • Low incidence of anti-pf4/heparin antibodies in patients with acute myelogenous leukemia.

    Håkon Reikvam, Ingvild Jenssen Lægreid, Ingvild Hausberg Sørvoll, Tom Sollid, Trude Victoria Mørtberg, Maria Therese Ahlén, Silje Johansen
    e2024057
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.057
    883
    PDF: 803
    HTML: 121
  • Bacillus cereus in the neutropenic patient: case report in a patient with myelodysplastic syndrome and review of the literature

    Mariam Markouli, Sevastianos Chatzidavid, Dimitra Vlachopoulou, Nefeli Giannakopoulou, Amalia Anastasopoulou, Nora-Athina Viniou, Panagiotis Diamantopoulos
    e2022071
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.071
    816
    PDF: 695
    HTML: 184
  • EBV CHRONIC INFECTIONS

    Eligio Pizzigallo, Delia Racciatti, Valeria Gorgoretti
    e2010022
    2010-08-09
    https://doi.org/10.4084/mjhid.2010.022
    3326
    PDF: 1528
    HTML: 7766
  • Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era

    Serena Vita, Emanuela Giacobini, Patrizia De Marco, Martina Rueca, Cesare Ernesto Maria Gruber, Alessia Beccacece, Laura Scorzolini, Valentina Mazzotta, Carmen Pinnetti, Priscilla Caputi, Daniele Focosi, Enrico Girardi, Andrea Antinori, Fabrizio Maggi, Alessandra D'Abramo, Emanuele Nicastri, Spallanzani COVID-19 case Investigation Team
    e2024043
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.043
    1194
    PDF: 894
    HTML: 80
1 - 50 of 85 items 1 2 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy